Background: Cancer results from genetic alterations that disturb the normal cooperative 3
Introduction 1
The current view of cancer is that tumorigenesis is due to the accumulation of mutations in 2 oncogenes, tumor suppressor genes, and genetic instability genes [1] . Sequential mutations in 3 these genes, lead to most of the hallmarks of cancer [2] . Cancer research has benefited 4 immensely from studies of uncommon inherited cancer syndromes that served to highlight the 5 importance of individual genes in tumorigenesis [3] . Theoretical considerations have suggested 6 that a handful of mutations, perhaps as few as three, may be sufficient for developing colorectal 7 cancer [4, 5] . This relatively small number is consistent with the standard model for colorectal 8 tumorigenesis based on the identification of mutations in well-known cancer genes [6] . 9
However, Sjöblom et al. [7] have recently determined the sequence of 13,000 genes in colorectal 10 cancers and found that individual tumors contained an average of 62 nonsynonymous mutations. 11
Extrapolating to the entire genome, it was estimated that individual colorectal cancers contain 12 about 100 nonsynonymous mutations and that as many as 20 of the mutated genes in individual 13 cancers might play a causal role in the neoplastic process [7] . 14 15 Tumors arise from a process of replication, mutation, and selection through which a single cell 16 acquires driver mutations which provide a fitness advantage by virtue of enhanced replication or 17 resistance to apoptosis [8] . Each driver mutation thereby allows the mutant cell to go through a 18 wave of clonal expansion. Along with drivers, passenger mutations, which do not confer any 19 fitness advantage, are frequently observed. Passenger mutations arise in advantageous clones and 20 become frequent by hitchhiking. The accumulation of ~100 mutations per cell is therefore the 21 result of sequential waves of clonal expansion; the observed mutations mark the history of the 22 cancer cell, including both drivers and passengers. 23 1 Genetic mutations can arise either due to errors during DNA replication or from exposure to 2 genotoxic agents. The normal mutation rate due to replication errors is in the range of 10 −10 to 3 10 −9 per nucleotide per cell per division [9] . It is likely that the initial steps leading to cancer 4 arise in cells with a normal mutation rate [10] . A normal mutation rate might also be sufficient 5 to generate the large numbers of mutations in cancer given the many generations that the 6 dominant cancer cell clone has gone through both before and after its initiating mutation [11, 12] . 7
However, it has also been argued that tumor cells have mutator phenotypes that accelerate the 8 acquisition of mutations [13] . 9 10 Mathematical modeling of carcinogenesis has had a rich history since its introduction more than 11 50 years ago [14, 15, 16] . The initial two-hit theory has evolved into more elaborate models 12 incorporating multiple hits, rate-limiting events and genomic instability [4, 17, 18, 19, 20, 21, 22] . 13
Most models consider the stem cell at the base of the colonic crypt as the initial target for 14 mutation, with the daughter cells giving rise to the adenoma and progressively increasing the risk 15 of malignant development [4, 21] . 16
17
The tumor data collected by Sjöblom et al. [7] show that the mutational patterns among 18 colorectal cancers from different patients are diverse. This observation indicates that there may 19 be many different mutational pathways that can lead to the same cancer phenotype. In the model 20 described below, we assume that there are 100 potential driver genes and ask for the expected 21
waiting time until one cell has acquired mutations in a given number, up to 20, of these genes. 22
We assume that one or two initial mutations, perhaps together with losses or gains of large 23 chromosomal regions [14, 15] , give rise to a benign tumor (adenoma) of ~1 milligram or 10 6 cells 1 (Fig. 1) . We model the progression of this adenoma to full blown cancer over a period of 5 to 20 2 years [15] , in which the adenoma grows to ~1 gram, or 10 9 cells. Whether the whole population 3 of cells is at risk for clonal expansion or whether a fraction of cells akin to stem cells drives 4 growth of the adenoma is currently a subject of debate. This is important as cancer stem cells, as 5 well as other factors such as geometric constraints on the architecture of the adenoma, may 6 significantly reduce the effective population size and thereby impact the waiting time to cancer 7 [23, 24] . Note that it is not size that distinguishes a cancer from an adenoma; rather it is the 8 ability of the cancer cells to invade through the underlying basement membrane and escape from 9 its normal anatomical position. 
Methods 19
Data. The collection of tumor data has been described in [7] . Briefly, ~13,000 genes were 20 sequenced from cancers of 11 patients with advanced colorectal cancers. Any mutant gene 21 detected in this study was analyzed in an additional 24 patients with advanced cancers. Tumors 22 with mismatch repair (MMR) deficiency were not included in this cohort, as MMR is known to 23 increase the mutation rate by orders of magnitude and would complicate the analysis of 1 mutations. Mutations were found in 519 genes and of these, 105 genes were found to be mutated 2 in at least two independent tumors. 3 4 Statistical analysis. In order to test for dependencies between mutated genes, we calculated all 5 3003 pair-wise partial correlations between the 78 genes that were considered candidate drivers. 6
Because the number of observed tumors is much smaller than the number of genes, we used the 7 shrinkage method introduced in [27] for estimation. . Ignoring back mutation, the 6 probability of sampling a j-fold mutant is 7
where u is the mutation rate per gene. In each generation, the population is updated by sampling 9 from the multinomial distribution 10
where N(t) follows the above growth kinetics. The mutation data are represented in a binary matrix of size 35 × 78 whose rows correspond to 6 35 tumor samples and whose columns correspond to the 78 candidate cancer genes identified by 7
Sjöblom et al. [7] (Fig. 2) . A non-zero entry in cell (i, j) of this matrix indicates the presence of 8 a mutation in gene j of tumor i. Tumors harbor between 1 and 20 mutated genes (mean = 6.5). 9
Most of these genes (66/78 = 85%) are mutated in at most 3 different tumors resulting in highly 10 diverse mutational patterns among the tumors. The notable exception are the three well-known 11 cancer genes APC, p53, and K-ras which were found mutated in 24, 17, and 16 tumors, 12 respectively. We have analyzed partial correlations between genes taking into account the small 13 number of observations and multiple comparisons. Several pairs of genes were significantly 14 correlated, most of them positively, but all correlations were weak and below 0.07 (Fig. S1) . adenoma. Adenoma formation probably requires the appearance of mutations in a few genes 22 (e.g., APC and K-ras) that are common to most tumors. We assume the occurrence of all 23 subsequent mutations to be independent events. When any k out of d = 100 susceptible genes are 1 mutated in a single cell, the cancer phenotype is considered to be attained. The first cells of this 2 type mark the onset of an invasive tumor. The Wright-Fisher process is used to describe these 3 evolutionary dynamics. Despite the large population size of up to N = 10 9 cells, we can 4 efficiently compute estimates of the time to the first appearance of any k-fold mutant by 5 simulation, because it suffices to trace the distribution of the k + 1 mutant error classes in each 6 generation. We assume a constant average selective advantage, s, for each mutation and a per-7 gene mutation rate, u. Figure 3 displays the typical behavior of this process in a single 8 simulation. After a short initial phase in which the homogeneous wild type population produces 9 the first low-order mutants, a traveling wave is observed (Fig. 3) . Apparently, this distribution of 10 error classes has constant variance and travels with constant velocity towards higher-order 11 mutants. Thus, we expect the time until the first k-fold mutant appears to be linear in k. This 12 conjecture is substantiated by simulations for a wide range of parameters (Fig. S2) provided that 13 mutations are advantageous (s > 0). 14 15 Within our model, the probability of developing cancer is equated with the probability of 16 generating at least one k-fold mutant cell in the adenoma. For k = 20, this probability as a 17 function of time is depicted in Figure 4 . The expected time to the development of cancer 18 increases with decreasing cell population size (hence the low risk of cancer associated with very 19 small adenomas), with decreasing selective advantage, and with decreasing mutation rate. Thus, 20 if the population at risk is a small subset composed of actively replicating stem cells, tumor 21 progression will be slow. In contrast, an increased mutation rate due to genetic instability speeds 22 up this process. 23
1
The simulations suggest that in a time frame of 5 to 15 years, cancer might develop in an 2 adenoma of size 10 7 to 10 9 cells with a normal mutation rate of 10 −7 per gene per cell division 3 and a 1% selective advantage per mutation (Fig. 4a) . Alternatively, a higher mutation rate of 10 (Fig. 4b) . However, for reasonable mutation rates, a completely neutral process (s = 0) 7 predicts waiting times that are not consistent with the observed incidence of colon cancer, as 8 would be expected (Fig, 4, Fig. S2 ). Wright-Fisher process that results in a 10% chance of developing a k-fold mutant after 3000 13 generations (or 8.2 years). These level curves define the parameter combinations that produce 14 similar dynamics. For example, a small at-risk population is unlikely to generate a cancer 15 requiring more than 10 driver gene mutations unless the selective advantage for these mutations 16 is large (see Discussion). 17
18
Based on the simulation results we have derived an analytical approximation for the expected 19 time to cancer. The key observation is that the distribution of error types follows a Gaussian (Fig.  20 3). This approach leads to the expression 21 The approximation is linear in k (Fig. S2) and matches closely the observed behavior of the 4 Wright-Fisher process, as long as s > 0 (Fig. 3-5) . The fit is analyzed quantitatively in the 5 supporting information S3. The expression for t k highlights the strong effect of the selective 6 advantage on tumorigenesis, and gives an explicit tradeoff between the evolutionary forces. 7 8 Discussion 9
Research over the past three decades has shown that cancer is an acquired genetic disorder [1] . 10
The process of replication, mutation, and selection eventually leads to the appearance of tumors 11 phenotypic effects [1] . This view is supported by the observation that multiple hits in different 1 genes of the same pathway in individual tumors are less frequent than expected [1] . 2 3 In our model, we assume that each subsequent mutation has the same incremental effect on the 4 fitness of the cell. In general, however, the impact of a specific mutation on the phenotype of the 5 cell will depend on the genetic background. Gene interactions, or epistasis, can be positive or 6 negative, and they can impose constraints on the order in which mutations accumulate [1] . In 7 this case, the model parameter s may be regarded as the average fitness increase per mutation. In 8 another simplifying abstraction, we have defined the tumor cell by the accumulation of 20 = k 9 mutations in different driver genes. In reality, it is unlikely that any combination of 20 genes will 10 induce the cancer phenotype. Our assumption is based on the observed cancer genotypes which 11 fail to reveal a striking genetic signature of cancer cells. In this respect, our model provides 12 lower bounds on the expected waiting time to cancer, as reaching a specific 20-fold mutant may 13 take significantly longer. The large population size of 10 9 cells would suggest that a purely deterministic approximation to 1 the Wright-Fisher process is reasonable. It turns out, however, that the stochasticity associated 2 with generating mutants of each new type has a strong impact on the evolutionary dynamics (see 3 supporting information S3). Therefore, a deterministic model of evolutionary dynamics will 4 significantly underestimate the time to cancer. The closer approximation presented here exploits 5 the regular behavior of the system of propagating a Gaussian distribution of error types and takes 6 into account stochastic effects in determining the speed of this traveling wave. Thus, stochastic 7 effects can play an important role even in very large populations. 8 9 Tumors derived from the same tissue exhibit considerable variability in their spectrum of 10 mutations ( Fig. 2 and [7] ). The number and type of mutations observed is the result of the size of 11 the population at risk, the mutation rate, and the microenvironment of the evolving clone. The 12 individual mutation rate can vary significantly due to genetic [29, 30] , and environmental effects 13 (e.g., dietary fat intake, colonic bacterial flora, prior genotoxic therapy) [31, 32] . These factors 14 that are expected to be different for every tumor also contribute to the diversity of the mutational 15 landscape observed in tumors. It is also worth noting that the number of potential driver genes is 16 likely to be an underestimate because the power of the Sjöblom et al. study to detect infrequent 17 mutations was limited [7] . The study of larger numbers of tumors is likely to show that a few 18 hundred different genes may function as drivers. This increase in potential drivers, however, 19 will not have a substantial effect on the conclusions of the models derived here (Eq. 1). 20 adenomas [38] . Thus, adenoma formation can be regarded as a mechanism by which the 10 population of cells at risk is increased and hence the probability of cancer in patients with 11 multiple adenomas is dramatically increased. This is observed in familial adenomatous polyposis 12 patients, who have inherited mutations of the APC gene. 13
14
Our model permits investigation of the impact of the relevant parameters of tumor evolution on a 15 global scale. These parameters include the size of the population at risk, the mutation rate, and 16 the fitness advantage conferred by specific mutations (Eq. 1). The model suggests that the 17 average waiting time for the appearance of the tumor is strongly affected by the fitness, s, 18 conferred by the mutations, with the average waiting time decreasing roughly as 1/s (Fig. S2) . 19
The mutation rate and the size of the population at risk contribute only logarithmically to the 20 waiting time and hence have a weaker impact. Thus, the model of cancer progression presented 21
here might add to the debate whether selection [10, 11] behave so differently with respect to their response to chemotherapeutic agents or radiation or 7 their propensity to metastasize? Our model is compatible with the view that a few major 8 mutational pathways, such as those involving APC, K-ras, and p53, endow relatively large 9 increases in fitness that can allow tumors to grow to sizes compatible with further progression 10 (Fig. 5) . However, the final course to malignancy will be determined by multiple mutations, 11 each with a small and distinct fitness advantage, and these mutations occur stochastically. Every 12 cancer will thereby be dependent on a unique complement of mutations that will determine its 13 propensity to invade, its ability to metastasize, and its resistance to therapies. If this model is 14 correct, then biological heterogeneity is a direct consequence of the tumorigenic process itself. 
